The advent of novel technologies in the field of autoinjectors has been pivotal in contributing to the growing demand of these devices worldwide. Adoption of latest technologies like variable dose drug delivery and feedback mechanism on time and dosage of drugs have been extremely beneficial in supporting the growth of this industry. For instance, SmartPilot technology for YpsoMate product line, manufactured by Ypsomed AG, offers several advanced features which enables administration of drugs with better efficiency and efficacy. Features like drug identification, reminder of injection time and date, variable dosage delivering capacity and feedback systems have raised the standards of drug delivery technologies, which is further anticipated mature in the coming years.
The Autoinjectors Market is segmented on the basis of Therapy, Types, End Users and region.
Major Therapy of Autoinjectors Market covered are:
- Rheumatoid Arthritis
- Multiple Sclerosis
- Diabetes
- Anaphylaxis
Major Types of Autoinjectors Market covered are:
- Disposable
- Reusable
Major End Users of Autoinjectors Market covered are:
- Home Care Settings
- Hospitals
- Clinics
Anaphylaxis is one of the most common type of chronic disease in the world. The occurrence of an anaphylactic episode or allergic reaction can range from mild to severe life-threatening outcomes. Emergency administration of the medication epinephrine, during an anaphylactic episode is extremely crucial to prevent any detrimental outcomes. According to World Allergy Organization (WAO), the estimated prevalence of allergy among the population of the world ranges between a staggering 10 to 40%. Rising incidences of anaphylaxis among the global population is anticipated to further contribute to the growing demand of autoinjectors.
No comments:
Post a Comment